Breadcrumb

FDA: Batteries in certain Medtronic pacemakers may deplete early

May 13, 2019 - 03:11 PM

The Food and Drug Administration last week alerted health care providers and patients that batteries in certain Medtronic implantable pacemakers and cardiac resynchronization therapy pacemakers may drain more quickly than expected without warning. The devices provide pacing for slow heart rhythms and heart failure. FDA said it has received three reports of the batteries draining early because of a crack in the device’s capacitor, resulting in one patient’s death. FDA recommends that providers advise their patients to continue to use their remote monitors, which can be set to alert the patient and provider when the battery level drops below a certain limit, and to immediately replace the device if they receive such a notice.

Noncommercial use of original content on www.aha.org is granted to AHA Institutional Members, their employees and State, Regional and Metro Hospital Associations unless otherwise indicated. AHA does not claim ownership of any content, including content incorporated by permission into AHA produced materials, created by any third party and cannot grant permission to use, distribute or otherwise reproduce such third party content. To request permission to reproduce AHA content, please click here.